IL117797A0 - Tricyclic compounds useful for inhibition of G-protein function and for treatment of proliferative diseases - Google Patents
Tricyclic compounds useful for inhibition of G-protein function and for treatment of proliferative diseasesInfo
- Publication number
- IL117797A0 IL117797A0 IL11779796A IL11779796A IL117797A0 IL 117797 A0 IL117797 A0 IL 117797A0 IL 11779796 A IL11779796 A IL 11779796A IL 11779796 A IL11779796 A IL 11779796A IL 117797 A0 IL117797 A0 IL 117797A0
- Authority
- IL
- Israel
- Prior art keywords
- inhibition
- treatment
- compounds useful
- proliferative diseases
- protein function
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US41898095A | 1995-04-07 | 1995-04-07 |
Publications (1)
Publication Number | Publication Date |
---|---|
IL117797A0 true IL117797A0 (en) | 1996-08-04 |
Family
ID=23660310
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IL11779796A IL117797A0 (en) | 1995-04-07 | 1996-04-02 | Tricyclic compounds useful for inhibition of G-protein function and for treatment of proliferative diseases |
Country Status (3)
Country | Link |
---|---|
AU (1) | AU5432796A (en) |
IL (1) | IL117797A0 (en) |
WO (1) | WO1996031505A1 (en) |
Families Citing this family (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6117641A (en) | 1996-04-11 | 2000-09-12 | Mitotix, Inc. | Assays and reagents for identifying anti-fungal agents and uses related thereto |
WO1997038293A2 (en) | 1996-04-11 | 1997-10-16 | Mitotix, Inc. | Assays and reagents for identifying anti-fungal agents, and uses related thereto |
US6727082B1 (en) | 1996-04-11 | 2004-04-27 | Gpc Biotech Inc. | Assays and reagents for identifying anti-fungal agents, and uses related thereto |
US6426352B1 (en) | 1997-06-17 | 2002-07-30 | Schering Corporation | Sulfonamide inhibitors of farnesyl-protein transferase |
US6225322B1 (en) | 1997-06-17 | 2001-05-01 | Schering Corporation | Compounds useful for inhibition of farnesyl protein transferase |
AU8253498A (en) * | 1997-06-17 | 1999-01-04 | Schering Corporation | Tricyclic compounds useful for inhibition of g-protein function and for treatment of proliferative diseases |
US5925639A (en) * | 1997-06-17 | 1999-07-20 | Schering Corporation | Keto amide derivatives useful as farnesyl protein transferase inhibitors |
ES2224408T3 (en) * | 1997-06-17 | 2005-03-01 | Schering Corporation | BENZOPIRIDOCICLOHEPTANO USEFUL COMPOUNDS FOR THE INHIBITION OF FARNESIL-PROTEIN-TRANSFERASE. |
JP2002507192A (en) * | 1997-06-17 | 2002-03-05 | シェーリング コーポレイション | Novel tricyclic sulfonamide inhibitors of farnesyl protein transferase |
EP1071648A2 (en) * | 1998-03-13 | 2001-01-31 | Merck Frosst Canada & Co. | Carboxylic acids and acylsulfonamides, compositions containing such compounds and methods of treatment |
US6242493B1 (en) | 1998-03-13 | 2001-06-05 | Merck Frosst Canada & Co. | Carboxylic acids and acylsulfonamides, compositions containing such compounds and methods of treatment |
US6372747B1 (en) | 1998-12-18 | 2002-04-16 | Schering Corporation | Farnesyl protein transferase inhibitors |
WO2005017160A2 (en) | 2003-08-13 | 2005-02-24 | Children's Hospital Medical Center | Mobilization of hematopoietic cells |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU665341B2 (en) * | 1990-12-18 | 1996-01-04 | Wellcome Foundation Limited, The | Agents for potentiating the effects of antitumor agents and combating multiple drug resistance |
JPH09500109A (en) * | 1993-06-18 | 1997-01-07 | メルク エンド カンパニー インコーポレーテッド | Inhibitors of farnesyl protein transferase |
ATE210653T1 (en) * | 1993-10-15 | 2001-12-15 | Schering Corp | TRICYCLIC SULFONAMIDE DERIVATIVES FOR INHIBITING G-PROTEIN FUNCTION AND FOR THE TREATMENT OF PROLIFERATIVE DISEASES |
TW308594B (en) * | 1993-10-15 | 1997-06-21 | Schering Corp | |
IL111235A (en) * | 1993-10-15 | 2001-03-19 | Schering Plough Corp | Pharmaceutical compositions for inhibition of g-protein function and for treatment of proliferative diseases containing tricyclic compounds some such compounds and process for preparing part of them |
-
1996
- 1996-04-02 IL IL11779796A patent/IL117797A0/en unknown
- 1996-04-03 AU AU54327/96A patent/AU5432796A/en not_active Abandoned
- 1996-04-03 WO PCT/US1996/004170 patent/WO1996031505A1/en active Application Filing
Also Published As
Publication number | Publication date |
---|---|
AU5432796A (en) | 1996-10-23 |
WO1996031505A1 (en) | 1996-10-10 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL117798A0 (en) | Tricyclic compounds useful for inhibition of G-protein function and for treatment of proliferative diseases | |
IL117603A0 (en) | Tricyclic compounds useful for inhibition of G-protein function and for treatment of proliferative diseases | |
HUP9903705A3 (en) | Tricyclic amides useful for inhibition of g-protein function and for treatment of proliferative diseases | |
AU5189196A (en) | Tricyclic carbamate compounds useful for inhibition of G-protein function and for treatment of proliferative diseases | |
IL117604A0 (en) | Tricyclic amide and urea compounds useful for inhibition of G-protein function and for treatment of proliferative diseases | |
IL117602A0 (en) | Tricyclic amide and urea compounds useful for inhibition of G-protein function and for treatment of proliferative diseases | |
AU2912997A (en) | Phenylamino-substituted tricyclic derivatives for treatment of hyperproliferative diseases | |
AU6594796A (en) | Photoactivatable compounds for the prevention of intimal hyperplasia and other diseases | |
IL119894A0 (en) | Thiazolidine derivatives for treatment of osteoporosis | |
IL117797A0 (en) | Tricyclic compounds useful for inhibition of G-protein function and for treatment of proliferative diseases | |
AU5901896A (en) | Use of aryl-substituted cyclobutylalkylamines for treating obesity | |
AU8058498A (en) | Carboxy piperidylacetamide tricyclic compounds useful for inhibition of g-protein function and for treatment of proliferative diseases (farnesyl protein transferase inhibitors) | |
IL115320A0 (en) | Retinoyloxy (substituted) methyl butyrates useful for the treatment of cancer and other proliferative diseases | |
EP0859761A4 (en) | 4-azasteroids for treatment of hyperandrogenic conditions | |
HK1002865A1 (en) | Tricyclic compounds useful for inhibition of g-protein function and for treatment of proliferative diseases | |
GB9502136D0 (en) | Treatment of waste | |
ZA9610735B (en) | Tricyclic amides useful for inhibition of g-protein function and for treatment of proliferative diseases | |
AU8253498A (en) | Tricyclic compounds useful for inhibition of g-protein function and for treatment of proliferative diseases | |
HUP9801338A3 (en) | Use of tricyclic carbamate derivatives for inhibition of g-protein function and for treatment of proliferative diseases | |
GB9508792D0 (en) | Surface treatment of materials | |
SI0828486T1 (en) | Use of pyrrolidine derivatives for treating alcoholism | |
GB9517498D0 (en) | Treatment of waste materials | |
GB9503795D0 (en) | Use of organic compounds | |
HU9503499D0 (en) | Method for treatment of sludges | |
GB9517143D0 (en) | Treatment of soil |